Publications by Professor Anthony Moorman - ePrints

Browsing publications by Professor Anthony Moorman.

Newcastle Authors	Title	Year
Professor Anthony Moorman	ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?	2024
Dr Amir Enshaei Melvin Joy Ellie Butler Professor Anthony Moorman	A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study	2024
Dr Hayden Bell Dr Helen Blair Samantha Jepson Gosling Dr Martin Galler Dan Astley et al.	Combination p53 activation and BCL-x_L/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	2024
Professor Anthony Moorman Dr Amir Enshaei Daniel Murdy Melvin Joy	Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction	2024
Professor Anthony Moorman	Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL	2024
Emilio Barretta Dr Tom Creasey Professor Anthony Moorman	Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia	2024
Professor Anthony Moorman	Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations	2024
Ellie Butler Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group	2023
Melvin Joy Dr Amir Enshaei Professor Anthony Moorman	Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL	2023
Dr Richard Gallon Rachel Phelps Christine Hayes Dr Dino Masic Professor Julie Irving et al.	Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia	2023
Dr Paul Sinclair Dr Ruth Cranston Prahlad Raninga Joanna Cheng Rebecca Hanna et al.	Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia	2023
Professor Anthony Moorman	EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy	2023
Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al.	Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial	2023
Dr Simon Bomken Dr Amir Enshaei Dr Ed Schwalbe Dr Aneta Mikulasova Dr Masood Zaka et al.	Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement	2023
Professor Anthony Moorman	Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials	2023
Dr Amir Enshaei Jude Gibson Dr Sulaiman Lawal Professor Anthony Moorman	Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform	2023
Dr Hayden Bell Dr Helen Blair Mankaran Singh Professor Anthony Moorman Professor Olaf Heidenreich et al.	Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	2023
Sarra Ryan Dr Ruth Cranston Claire Schwab Dr Matthew Bashton Dr Paul Sinclair et al.	The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21	2023
Dr Amir Enshaei Professor Anthony Moorman	The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia	2023
Sarra Ryan Claire Schwab Dr Richard Yim Dr Ruth Cranston Dr Lisa Russell et al.	Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia	2023
Professor Anthony Moorman	Activity and toxicity of intramuscular 1000 iu/m² polyethylene glycol-E. coli L-asparaginase in the UKALL 2003 and UKALL 2011 clinical trials	2022
Dr Tobias Menne Professor Anthony Moorman	Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial	2022
Professor Anthony Moorman	Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse	2022
Dr Tom Creasey Emilio Barretta Dr Sarra Ryan Ellie Butler Dr Daniel Leongamornlert et al.	Genetic and genomic analysis of acute lymphoblastic leukaemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials	2022
Claire Schwab Daniel Murdy Ellie Butler Dr Amir Enshaei Emily Winterman et al.	Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification	2022
Angeli Ambayya Professor Anthony Moorman Dr Jeyanthy Eswaran Sarina Sulong	Genetic profiles and risk stratification in adult de novo acute myeloid leukaemia in relation to age, gender, and ethnicity: A study from Malaysia	2022
Dr Deepali Pal Dr Helen Blair Sean Hockney Dr Melanie Beckett Mankaran Singh et al.	hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia	2022
Dr Tobias Menne Professor Anthony Moorman	In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial	2022
Professor Anthony Moorman Emilio Barretta Ellie Butler Eleanor Ward Dr Amir Enshaei et al.	Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study	2022
Professor Anthony Moorman Dr Lina Hamadeh	Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols	2022
Professor Anthony Moorman Dr Grace Antony Ellie Butler Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci et al.	Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial	2022
Claire Schwab Professor Anthony Moorman	SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome	2021
Ellie Butler Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group	2021
Dr Amir Enshaei Professor Anthony Moorman	Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials	2021
Daniel Murdy Professor Anthony Moorman	DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia	2021
Emilio Barretta Dr Tobias Menne Professor Anthony Moorman	IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial	2021
Dr Amir Enshaei Professor Anthony Moorman	Minimal Residual Disease, Long-Term Outcome, and IKZF1 Deletions in Down Syndrome Acute Lymphoblastic Leukemia in a Matched Cohort Study	2021
Professor Anthony Moorman Professor Julie Irving	Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials	2021
Dr Tom Creasey Dr Amir Enshaei Claire Schwab Kathryn Watts Gavin Cuthbert et al.	Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia	2021
Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci Claire Schwab Professor Anthony Moorman	A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia	2020
Professor Anthony Moorman Claire Schwab Emily Winterman Dr Frederik van Delft Professor Christine Harrison FRCPath FMedSci et al.	Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion	2020
Dr Ed Schwalbe Dr Peter Carey Professor Stephen O'Brien Professor Anthony Moorman Emilio Barretta et al.	Challenges of starting treatment protocols for acute lymphoblastic leukaemia in a low-income setting — the Blantyre experience	2020
Dr Matthew Bashton Robin Hollis Dr Sarra Ryan Claire Schwab Professor Christine Harrison FRCPath FMedSci et al.	Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia	2020
Professor Anthony Moorman	Germline variants in predisposition genes in children with down syndrome and acute lymphoblastic leukemia	2020
Professor Anthony Moorman	IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?	2020
Dr Jennifer Warrender Professor Anthony Moorman Dr Phillip Lord	A fully computational and reasonable representation for karyotypes	2019
Professor James Allan Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Author correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia	2019
Professor Anthony Moorman Dr Amir Enshaei Dr Tobias Menne	Clinical Efficacy of a Novel Validated Prognostic Index for Trial Design in Adult Acute Lymphoblastic Leukaemia	2019
Dr Amir Enshaei Professor Anthony Moorman	Combining Genotype Profiling with MRD for More Accurate Prognostication in Acute Lymphoblastic Leukemia	2019
Professor James Allan Professor Anthony Moorman	Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk	2019
Professor Anthony Moorman Dr Amir Enshaei	Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study	2019
Dr Lina Hamadeh Professor Julie Irving Professor Anthony Moorman	Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial	2019
Dr Paul Sinclair Dr Sarra Ryan Dr Matthew Bashton Shaun Hollern Rebecca Hanna et al.	SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain	2019
Dr Tom Creasey Dr Amir Enshaei Kathryn Watts Gavin Cuthbert Claire Schwab et al.	Single Nucleotide Polymorphism Array-Based Signature of Genetic Ploidy Groups in Acute Lymphoblastic Leukemia	2019
Dr Lina Hamadeh Dr Amir Enshaei Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman et al.	Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL	2019
Dr Peixun Zhou Dr Amir Enshaei Alex Newman Dr Amy Erhorn Amy Barnard et al.	A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma	2018
Dr Peixun Zhou Dr Amir Enshaei Alex Newman Dr Amy Erhorn Amy Barnard et al.	A Genomic Classification Model Enables Risk Stratification of Paediatric Endemic Burkitt Lymphona in Malawi	2018
Dr Paul Sinclair Dr Helen Blair Dr Sarra Ryan Dr Lars Buechler Joanna Cheng et al.	Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21	2018
Professor James Allan Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia	2018
Professor Julie Irving Professor Anthony Moorman	International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia	2018
Dr Lucy Chilton Professor Anthony Moorman Richard Feltbower	Long-term survival after childhood acute lymphoblastic leukaemia: Population-based trends in cure and relapse by clinical characteristics	2018
Dr Kate Potter Professor Anthony Moorman Professor Caroline Relton Professor John Mathers Dr Gordon Strathdee et al.	Maternal red blood cell folate and infant vitamin B12 status influence methylation of genes associated with childhood acute lymphoblastic leukaemia	2018
Dr Sarah Jenkinson Dr Sujith Samarasinghe Professor Anthony Moorman	Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial	2018
Professor Anthony Moorman	Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: Results from UKALL2003	2018
Professor Anthony Moorman	The genetic basis and cell of origin of mixed phenotype acute leukaemia	2018
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL	2018
Professor Anthony Moorman Professor Julie Irving Professor James Allan Professor Christine Harrison FRCPath FMedSci	A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1	2017
Professor Anthony Moorman Dr Halima Al-shehhi	Acute lymphoblastic leukemia with aleukemic prodrome: Preleukemic dynamics and possible mechanisms of immunosurveillance	2017
Dr Lucy Chilton Professor Christine Harrison FRCPath FMedSci Daniel Murdy Professor Anthony Moorman	Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia	2017
Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe Claire Schwab Professor Anthony Moorman et al.	Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia	2017
Claire Schwab Dr Lucy Chilton Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?	2017
Professor Anthony Moorman	Time for ALL adults to catch up with the children	2017
Professor Anthony Moorman Claire Schwab Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Use of minimal residual disease assessment to redefine induction failure in pediatric acute lymphoblastic leukemia	2017
Claire Schwab Sarra Ryan Dr Lucy Chilton Alannah Elliott James Murray et al.	EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications	2016
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Acute lymphoblastic leukaemia	2016
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Sarra Ryan et al.	Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia	2016
Professor Anthony Moorman Claire Schwab	Characterization of leukemias with ETV6-ABL1 fusion	2016
Dr Sujith Samarasinghe Professor Anthony Moorman	Early immature T-ALL as determined by absence of bi-allelic deletion at the TCR gamma locus is not an adverse prognostic factor on the MRC UKALL2003 trial	2016
Professor Anthony Moorman	Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia	2016
Professor Anthony Moorman Dr Amir Enshaei Dr Sujith Samarasinghe	Integrating Genetic Risk Factors with Age, Presenting White Cell Count and MRD Response As Continuous Variables to Predict Relapse in Paediatric Acute Lymphoblastic Leukemia (ALL)	2016
Professor Julie Irving Dr Amir Enshaei Dr Amy Erhorn Lynne Minto Claire Schwab et al.	Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukaemia	2016
Professor Anthony Moorman	New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia	2016
Claire Schwab Dr Amir Enshaei Dr Lisa Russell Professor Anthony Moorman	The Frequency and Outcome of Ph-like ALL Associated Abnormalities in Childhood Acute Lymphoblastic Leukaemia Treated on MRC UKALL2003	2016
Dr Sarra Ryan Elizabeth Matheson Dr Paul Sinclair Dr Matthew Bashton Claire Schwab et al.	The role of the RAS pathway in iAMP21-ALL	2016
Professor Julie Irving Professor Anthony Moorman	Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients	2015
Dr Al Gabriel Dr Amir Enshaei Jennifer Taylor Dr Amy Erhorn Claire Schwab et al.	Age specific incidence of partner gene and secondary abnormalities in MLL positive acute lymphoblastic leukaemia (ALL)	2015
Professor Anthony Moorman Claire Schwab Karen Marshall	Characterization of Leukemias with ETV6-ABL1 Fusion	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Dr Stefano Tonin Dr Sarra Ryan et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Dr Lisa Russell Lisa Jones Dr Amir Enshaei Jamie Rutherford Dr Stefano Tonin et al.	Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia	2015
Professor Anthony Moorman Professor Julie Irving Dr Amir Enshaei Dr Amy Erhorn Lynne Minto et al.	Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia	2015
Dr Al Gabriel Fadhel Alsaid Naji Dr Ed Schwalbe Dr Sirintra Nakjang Dr Simon Cockell et al.	Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia	2015
Professor Olaf Heidenreich Professor Anthony Moorman	Genomic and Drug Response Profiling of Fatal TCF3-HLF-Positive Pediatric Acute Lymphoblastic Leukaemia Identifies Recurrent Mutation Patterns and Novel Therapeutic Options	2015
Professor Olaf Heidenreich Professor Anthony Moorman	Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options	2015
Professor Anthony Moorman	High Frequency and Poor Outcome of Ph-like Acute Lymphoblastic Leukemia in Adults	2015
Dr Amir Enshaei Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Integration of Minimal Residual Disease with Other Patient Risk Factors Identifies a Population with Very Poor Overall Survival in Pediatric ALL: Results from the UKALL 2003 Trial	2015
Dr Amir Enshaei Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD: Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003	2015
Dr Amir Enshaei Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci Dr Sujith Samarasinghe	Long Term Overall Survival of Greater Than 98% in Childhood ALL Patients with Good Risk Features and Low Risk MRD:A Results from a Large Multi-Center Randomized Controlled Trial, UKALL 2003	2015
Dr Lucy Chilton Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Prognostic Significance and Risk Stratification in Acute Myeloid Leukaemia Patients in the Absence of Successful Cytogenetic Analysis	2015
Claire Schwab Dr Amir Enshaei Professor Anthony Moorman	Prognostic value of rare IKZF1 deletion in childhood b-cell precursor acute lymphoblastic leukemia: an international collaborative study	2015
Professor Anthony Moorman	Relapse in Teenage and Young Adult (TYA) Patients Treated on a Pediatric Minimal Residual Disease (MRD) Stratified Protocol Is Associated with a Poor Outcome: Results from UKALL2003	2015
Dr Amir Enshaei Claire Schwab Dr Lucy Chilton Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman et al.	Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy	2015
Dr Amir Enshaei Claire Schwab Dr Lucy Chilton Professor Anthony Moorman	Risk Factor Analysis in Paediatric Acute Lymphoblastic Leukaemia with High Hyperdiploidy	2015
Claire Schwab Alannah Elliott Dr Lucy Chilton Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci et al.	Targeted Sequencing Identifies Association Between IL7R-JAK Mutations And Epigenetic Modulators In T-Cell Acute Lymphoblastic Leukemia.	2015
Professor Anthony Moorman Professor Julie Irving Professor James Allan Professor Christine Harrison FRCPath FMedSci	The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A	2015
Professor Anthony Moorman	Use of Morphological Early Response Data to Predict Relapse in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)	2015
Dr Lisa Russell Dr Amir Enshaei Lisa Jones Dr Amy Erhorn Dr Dino Masic et al.	IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor Outcome	2014
Claire Schwab Dr Amir Enshaei Professor Anthony Moorman	368 Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study	2014
Professor Anthony Moorman Dr Amir Enshaei Claire Schwab Dr Lucy Chilton Alannah Elliott et al.	A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia	2014
Professor Anthony Moorman	Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group	2014
Dr Lucy Chilton Professor Anthony Moorman	Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials	2014
Professor Anthony Moorman	Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial	2014
Professor Anthony Moorman Dr Tobias Menne	CD20 Expression in Adults with Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) from UKALL14, its Regulation by Dexamethasone and Rituximab Induced Cytotoxicity	2014
Claire Schwab Sarra Ryan Professor Anthony Moorman Dr Richard McNally Professor Bryan Young et al.	Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia	2014
Professor Anthony Moorman	Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements	2014
Professor Anthony Moorman	Does TP53 guard ALL genomes?	2014
Claire Schwab Becca Andrews Dr Lucy Chilton Alannah Elliott Gerald Keil et al.	EBF1-PDGFRB Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications	2014
Dr Lucy Chilton Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome	2014
Dr Lucy Chilton Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Hyperdiploidy with 49-65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome.	2014
Fadhel Alsaid Naji Dr Vikki Rand Professor Anthony Moorman Dr Ed Schwalbe Dr Amir Enshaei et al.	Investigation of methylation based biomarkers for prediction of relapse in good prognostic cytogenetic subgroups of childhood acute lymphoblastic leukaemia	2014
Claire Schwab Professor Anthony Moorman	Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology	2014
Professor Anthony Moorman	No Evidence That PTEN Abnormalities Impact on Outcome in Pediatric Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated on the MRC UKALL2003 Trial	2014
Professor Anthony Moorman	Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003	2014
Professor Anthony Moorman	Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia - Prospective Open Cohort Analyses of the ALLR3 Trial	2014
Professor Anthony Moorman	Potential Involvement of Physiological TCR Gamma Delta Clones in Immune Surveillance of Preleukemic Cells	2014
Claire Schwab Dr Amir Enshaei Professor Anthony Moorman	Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study	2014
Claire Schwab Becca Andrews Dr Lucy Chilton Alannah Elliott Dr Stacey Richardson et al.	SSBP2-CSF1R Is a Recurrent Fusion in B-Other Acute Lymphoblastic Leukaemia with Variable Clinical Outcome	2014
Professor Anthony Moorman	Telomere DNA content and TP53 state provide an insight into genomic instability in older adult patients with all	2014
Professor Anthony Moorman	TP53 Alterations Are Frequent in Patients over 60 Years with B-Precursor Acute Lymphoblastic Leukemia (ALL) and Low Hypodiploid/Near Triploid (HoTr) Karyotype; They Correlate with RB1 Deletion and Leukemic Telomere Gain	2014
Professor Anthony Moorman	UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia	2014
Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia	2013
Dr Halima Al-shehhi Claire Schwab Dr Amy Erhorn Dr Al Gabriel Professor Christine Harrison FRCPath FMedSci et al.	Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia	2013
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman Claire Schwab Dr Lucy Chilton	An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome	2013
Dr Lucy Chilton Professor Anthony Moorman	Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements	2013
Claire Schwab Dr Lucy Chilton Heather Morrison Lisa Jones Dr Halima Al-shehhi et al.	Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features	2013
Dr Sarah Jenkinson Professor Anthony Moorman	Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial	2013
Professor Anthony Moorman Dr Amir Enshaei Claire Schwab Dr Lucy Chilton	Integration Of Cytogenetic and Copy Number Alteration (CNA) Data Into a Single Risk Profile For Paediatric Acute Lymphoblastic Leukaemia (ALL)	2013
Dr Amir Enshaei Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor	2013
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia	2013
Professor Anthony Moorman Claire Schwab Professor Christine Harrison FRCPath FMedSci	Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials	2013
Professor Anthony Moorman Dr Lucy Chilton Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci	The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated on UKALLXII/ECOG2993	2013
Professor Anthony Moorman Dr Lucy Chilton Dr Amir Enshaei Professor Christine Harrison FRCPath FMedSci	The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial	2013
Dr Peter Carey Claire Schwab Dr Lucy Chilton Dr Ed Schwalbe Professor Roderick Skinner et al.	Treating childhood acute lymphoblastic leukemia in Malawi	2013
Dr Lisa Russell Hannah Ensor Professor Anthony Moorman	Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia	2013
Professor Anthony Moorman Claire Schwab Hannah Ensor Dr Lisa Russell Heather Morrison et al.	IGH@ Translocations, CRLF2 Deregulation and Microdeletions in Adolescents and Adults with Acute Lymphoblastic Leukemia	2012
Claire Schwab Dr Lucy Chilton Dr Amir Enshaei Heather Morrison Lisa Jones et al.	Clinical Relevance of Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL)	2012
Professor Anthony Moorman Dr Amir Enshaei Dr Lucy Chilton Claire Schwab Professor Christine Harrison FRCPath FMedSci et al.	Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics	2012
Shabnam Thathia Stuart Ferguson Hannah Gautrey Sanne Van Otterdijk Dr Vikki Rand et al.	Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity	2012
Claire Schwab Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia	2012
Claire Schwab Dr Lucy Chilton Heather Morrison Lisa Jones Dr Halima Al-shehhi et al.	Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL) Are Associated with Major Cytogenetic Subgroups	2012
Professor Anthony Moorman	IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia	2012
Professor Anthony Moorman	Immunophenotype and Cytogenetic Characteristics in the Relationship Between Birth Weight and Childhood Leukemia	2012
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman Claire Schwab	Intrachromosomal Amplification of Chromosome 21(iAMP21): Cytogenetic Characterisation and Outcome in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia (BCP-ALL). A Study On Behalf of the Ponte Di Legno International Childhood ALL Workshop	2012
Dr Lisa Russell Claire Schwab Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations	2012
Professor Anthony Moorman	Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial	2012
Professor Anthony Moorman	The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia	2012
Hannah Ensor Claire Schwab Dr Lisa Russell Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman et al.	Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups	2012
Professor Simon Bailey Professor Roderick Skinner Dr Peter Carey Professor Anthony Moorman	Acute lymphoblastic leukarmia (ALL) in Malawi, progress in the first Malawi ALL protocol	2011
Professor Anthony Moorman	Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Report From the Ponte Di Legno Study Group	2011
Hannah Ensor Claire Schwab Dr Lisa Russell Heather Morrison Dr Dino Masic et al.	Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial	2011
Dr Frederik van Delft Professor Anthony Moorman	Genetic variegation of clonal architecture and propagating cells in leukaemia	2011
Dr Vikki Rand Dr Lisa Russell Claire Schwab Hannah Ensor Professor Julie Irving et al.	Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia	2011
Professor Anthony Moorman	Intramuscular PEG-Asparaginase At 1000 U/m(2) Achieves Adequate Trough Activity Levels in the Majority of Patients Treated on the UKALL 2003 Childhood Acute Lymphoblastic Leukemia (ALL) Protocol	2011
Professor Anthony Moorman	Mutations in a Large Cohort of Young Adult Patients with Core Binding Factor Acute Myeloid Leukemia: Impact on Outcome and the Selection of Patients for Alternative Treatment Including Transplantation in First Complete Remission	2011
Professor Anthony Moorman Dr Lucy Chilton Dr Jennifer Wilkinson Hannah Ensor Dr Nicholas Bown et al.	A population-based cytogenetic study of adults with acute lymphoblastic leukemia	2010
Professor Anthony Moorman Dr Lucy Chilton Dr Jennifer Wilkinson Hannah Ensor Natalie Bown et al.	Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England Response	2010
Professor Anthony Moorman	Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study	2010
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12	2010
Dr Craig Parker Dr John Hancock Professor Anthony Moorman Mike Morgan Dr Nicola Green et al.	Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial	2010
Professor Anthony Moorman	Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial	2010
Professor Anthony Moorman	Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial	2010
Professor Anthony Moorman	Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993	2010
Professor Anthony Moorman	Mitoxantrone Improves the Outcome of Children with Central Nervous System (CNS) Involvement at First Relapse of Acute Lymphoblastic Leukemia (ALL)-Results of the International ALLR3 Study	2010
Professor Anthony Moorman	Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups	2010
Professor Anthony Moorman Hannah Ensor Dr Lucy Chilton Claire Schwab Professor Christine Harrison FRCPath FMedSci et al.	Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial	2010
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Refinement of cytogenetic classification in acute myeloid leukaemia: Determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials	2010
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials	2010
Professor Anthony Moorman	Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001	2010
Professor Julie Irving Professor James Allan Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk	2010
Sarina Sulong Professor Anthony Moorman Professor Julie Irving Marian Case Professor Simon Bailey et al.	A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups	2009
Dr Lisa Russell Professor Olaf Heidenreich Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	A novel translocation, t(14;19)(q32;p13) involving IGHalpha and the cytokine receptor for erythropoietin	2009
Dr Lisa Russell Professor Olaf Heidenreich Professor Julie Irving Professor Anthony Moorman Heather Morrison et al.	Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia	2009
Professor Anthony Moorman Dr Michael Griffiths Dr Tina Davies Professor Christine Harrison FRCPath FMedSci	Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21	2009
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia	2009
Professor Anthony Moorman Dr Michael Griffiths Professor Julie Irving Professor Christine Harrison FRCPath FMedSci	Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukaemia	2009
Dr David Milligan Professor Anthony Moorman	Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials	2009
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97	2009
Professor Anthony Moorman	Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993	2009
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Refinement of cytogenetic classification in AML: Determination of prognostic significance of rare recurring chromosomal abnormalities amongst 5635 younger adults treated in the UK MRC Trails	2009
Professor Anthony Moorman	T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)	2009
Dr Vikki Rand Dr Lisa Russell Professor Julie Irving Lisa Jones Dr Dino Masic et al.	What Is the Initiating Mechanism of iAMP21 in Childhood B Cell Precursor ALL?	2009
Professor Anthony Moorman	Acute leukemia in children with Down's syndrome: the importance of population based study	2008
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL)	2008
Elizabeth Matheson Lynne Minto Professor Anthony Moorman Dr Andrew Hall Professor Julie Irving et al.	Heterogeneous breakpoints target PAX5 in acute lymphoblastic leukaemia patients with dicentric chromosomes	2008
Dr Lisa Russell Professor Anthony Moorman Professor Olaf Heidenreich Professor Christine Harrison FRCPath FMedSci	IGH@ Translocations Involving the Pseudoautosomal Region 1 (PAR1) of Both Sex Chromosomes Deregulate the Cytokine Receptor-Like Factor 2 (CRLF2) Gene in B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)	2008
Professor Anthony Moorman Sarina Sulong Professor Julie Irving Marian Case Lynne Minto et al.	Inactivation of CDKN2A in childhood acute lymphoblastic leukaemia (ALL) occurs principally by deletion and is strongly correlated with cytogenetic subgroups	2008
Professor Anthony Moorman	One man's dose, another man's poison	2008
Professor Anthony Moorman	Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)	2008
Dr Lisa Russell Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)	2008
Marian Case Dr Tina Davies Professor Anthony Moorman Dr Andrew Hall Professor Julie Irving et al.	The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1	2008
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)	2008
Elizabeth Matheson Professor Anthony Moorman Dr Andrew Hall Professor Christine Harrison FRCPath FMedSci Professor Julie Irving et al.	Variable breakpoints target PAX5 in patients with dicentric chromosomes: A model for the basis of unbalanced translocations in cancer	2008
Dr Frederik van Delft Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization	2007
Professor Anthony Moorman Marian Case Professor Julie Irving Dr Andrew Hall Professor Christine Harrison FRCPath FMedSci et al.	Genomic profiling reveals multiple genetic targets in ETV6-RUNX1 positive acute lymphoblastic leukaemia (ALL)	2007
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Intrachromosomal amplification of chromosome 21 (iAMP21) arises from a breakage-fusion-bridge cycle	2007
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial	2007
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Molecular cytogenetic characterisation of TCF3 (E2A)/19p13 rearrangements in acute lymphoblastic leukaemia	2007
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)	2007
Professor Anthony Moorman	Sequential influences of leukaemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukaemia 14 and 15 trials	2007
Elizabeth Matheson Lynne Minto Professor Anthony Moorman Dr Andrew Hall Professor Julie Irving et al.	Variable Breakpoints Target PAX5 in Patients with Dicentric Chromosomes: A Model for the Basis of Unbalanced Translocations in Cancer	2007
Professor Anthony Moorman Dr Nicholas Bown Professor Christine Harrison FRCPath FMedSci	PAX5-ETV6 fusion in acute lymphoblastic leukaemia des not define the dic(9;12)	2006
Professor Anthony Moorman Professor Stephen Proctor	Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia	2006
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications	2005
Professor Anthony Moorman	Breakpoints of variant 9;22 translocations in chronic myeloid leukemia location preferentially in the CG-richest regions of the genome	2005
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia	2005
Professor Anthony Moorman	Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial	2005
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study	2005
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities	2005
Professor Anthony Moorman	Outcome after first relapse in childhood acute lymphoblastic leukaemia: lessons from the United Kingdom R2 trial	2005
Professor Anthony Moorman	RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years	2005
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Amplification of the ABL gene in T-cell acute lymphoblastic leukemia	2004
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemia	2004
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?	2004
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	MLL translocations with concurrent 3' deletions: interpretation of FISH results	2004
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	t(14;19)(q32;q13): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia	2004
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia	2004
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome	2003
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases	2003
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukaemia - response to Cuneo et al.	2003
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia	2003
Professor Anthony Moorman Dr Nicholas Bown Dr Penelope Taylor Professor Stephen Proctor	Population-based study of unselected acute myeloid leukemia cases reveals distinct cytogenetic pathways analogous to therapy-related AML/MDS	2003
Professor Anthony Moorman	Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia	2002
Professor Anthony Moorman	Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities	2002
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Involvement of the MLL gene in T-lineage acute lymphoblastic leukaemia	2002
Professor Anthony Moorman	Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK	2002
Professor Anthony Moorman	Sex ratios and the risks of haematological malignancies	2002
Professor Anthony Moorman	Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups	2002
Richard Feltbower Professor Anthony Moorman	Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK	2001
Professor Anthony Moorman	Karyotype and age in acute myeloid leukaemia: are they linked?	2001
Professor James Allan Professor Anthony Moorman	Polymorphism in glutathione S-transferase PI is associated with susceptibility to chemotherapy-induced leukaemia	2001
Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci	Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukaemia	2000
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman Emeritus Professor Alan Craft Dr Juliet Hale Dr Jennifer Kernahan et al.	The United Kingdom Childhood Cancer Study: objectives, materials and methods	2000
Professor Anthony Moorman	Derivative chromosomes of 11q23-translocations in hematologic malignancies	1998
Professor Anthony Moorman	Hematologic malignancies with t(4;11)(q21;q23) - a cytogenetic, morphologic, immunophenotypic, and clinical study of 183 cases	1998
Professor Anthony Moorman	Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects	1998
Professor Anthony Moorman	Hematological malignancies with t(9;11)(p21-22;q23) - a laboratory and clinical study of 125 cases	1998
Professor Anthony Moorman	Myelodysplastic syndromes associated with 11q23 abnormalities	1998
Professor Anthony Moorman	Secondary acute leukaemia and myelodysplastic syndrome with 11q23 abnormalities	1998
Professor Christine Harrison FRCPath FMedSci Professor Anthony Moorman	Ten novel 11q23 chromosomal partner sites	1998
Professor Anthony Moorman	The t(10;11)(p12;q23) translocation in acute leukemia: a cytogenetic and clinical profile of 20 patients	1998
Professor Anthony Moorman	The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases	1998
Professor Anthony Moorman	The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients	1998
Professor Anthony Moorman	Isochromosomes in acute lymphoblastic leukaemia: i(21q) is a significant finding	1996
Professor Anthony Moorman	Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia	1996
Professor Anthony Moorman	Complex hyperdiploidy in acute myeloid leukaemia: a United Kingdom Cancer Cytogenetics Group Study	1995
Professor Anthony Moorman	Association of 17p loss with late-stage or refractory disease in hematologic malignancy	1994